OBJECTIVE: Assess placental opioid metabolism (POM) of methadone and buprenorphine to predict treatment for severe neonatal abstinence syndrome (NAS). STUDY DESIGN: Multi-center prospective observational cohort study (July 2016 to December 2017. Eligible pregnant women: ! 18 years old, on methadone or buprenorphine, delivering a non-anomalous live-born singleton infant ! 34 weeks. Severe NAS was defined by Finnegan scoring: 3 consecutive scores !8 or sum of 3 consecutive scores !24 occurring 72 hours after birth. QPCR-derived placental aromatase mRNA levels (PmRNA) were compared to reference genes-actin, glyceraldehyde-3-phosphate dehydrogenase and glucuronidase beta. PmRNA and aromatase gene single nucleotide polymorphisms (SNPs: rs749292, rs727479, rs93606) were compared to Finnegan scores. SNPs assessed POM. Finnegan scores were compared to umbilical cord (UC) drugs and their metabolites. Data analysis: descriptive, parametric, non-parametric statistics, survival curves. Significance was set to p <0.05 to detect a large difference (cohen¼1) in PmRNA. RESULTS: 38 patients were included. 36/38 (95%) were Caucasian and mean delivery was at 38.5 AE 1.6 weeks. 29/38 (76%) and 9/38 (24%) used methadone and buprenorphine respectively. Severe NAS was present in 19/38 (50%) of infants, 16/19 (84%) used methadone and 3/19 (16%) used buprenorphine (p ¼0.02). There was no difference in maternal methadone or buprenorphine dose, UC methadone, UC buprenorphine and metabolites levels (EDDP, norbuprenorphine) (p>0.05) between groups. PmRNA were lower in severe NAS. However, only significant for the aromatase/Actin expression (severe NAS 0.52AE 0.34 vs. non-severe NAS 0.76AE0.36, p¼0.04). Mean UC EDDP/methadone ratio was significantly higher (0.68 vs 0.36, p ¼0.03) in infants meeting criteria for severe NAS vs those not meeting criteria; not so for norbuprenorphine/ buprenorphine ratios (2.44 vs.1.41, p¼0.59). SNP genotypes did not predict severe NAS (p >0.05), but sample size was underpowered. PmRNA were weakly to moderately correlated with UC methadone, buprenorphine and their metabolites (r ¼0.4-0.8). CONCLUSION: Maternal dose and umbilical cord levels of methadone and buprenorphine were not significantly different in neonates with or without severe NAS. However, PmRNA are lower and UC EDDP/ methadone ratios higher in severe NAS. Additional investigation of PmRNA and SNP analysis is needed to assess placental opioid metabolism to predict severe NAS.
935 Can cerebroplacental ratios predict perinatal and delivery outcomes for viable fetuses?
Ayesha Hussain, Claudia Taboada, Yijin Wirt UPMC PInnacle, Harrisburg, PA OBJECTIVE: To evaluate the relationship between fetal ultrasound assessments and perinatal and delivery outcomes in singleton term pregnancies. STUDY DESIGN: A retrospective cohort study of singleton deliveries ! 24 weeks' gestation was conducted at a community hospital between January 2016 and January 2018. The fetal cerebroplacental ratio (CPR) is the ratio of the fetal middle cerebral artery (MCA) pulsatility index (PI) to umbilical artery (UA) PI. CPR is gaining momentum to be a proxy for suboptimal fetal growth as it quantifies suboptimal placental function and subsequent fetal circulatory adaptations. We hypothesize the use of CPR as a generalized marker and potential screening tool as it looks as placental resistance and fetal physiologic response to reach growth potential for Small for Gestational Age (SGA) fetuses and Appropriate for Gestational Age (AGA) fetuses. The UA PI, MCA PI, and CPR were compared to maternal BMI, fetal weight at birth, delivery outcomes, and APGAR scores. Logistic regression analysis was performed to identify, and adjust for, potential confounders using SAS version 9.4 with a p < 0.05 considered as significant. RESULTS: The study cohort included 1732 singleton pregnancies. CPR had a linear association with fetal weight and gestational age (p < 0.0001). The average CPR ratio of spontaneous vaginal deliveries was higher than of caesarean-sections (C-sections) (p¼ 0.0193). The average UA PI of spontaneous vaginal deliveries was lower than of Csections (p¼ 0.0150). The CPR had a weak positive and UA PI ratio had a weak negative correlation with APGAR score at 1 and 5 minutes. CPR and UA PI had no significant association with maternal BMI (p¼ 0.2330). CONCLUSION: Our study shows that lower fetal CPR is associated with higher C-section rates in both SGA and AGA fetuses. Since low CPR is directly correlated with an elevated UA PI Doppler, this surveillance may be independently associated with delivery outcomes. These fetal ultrasound assessments may be valuable in predicting delivery outcomes of pregnancies at risk of operative deliveries, potential placental hypoxemia and cerebral redistribution affecting long-term neurodevelopmental disability.
Poster Session V ajog.org OBJECTIVE: Exclusive human breast milk feeding has been definitively shown to be optimal, and is uniformly endorsed, including by the WHO and AAP. Donor human milk banks have transformed modern neonatal nutritional care, and aim to eliminate over-exposure to formula feeding. Donor milk, when compared to formula, has decreased the rates of necrotizing enterocolitis in extremely low birthweight neonates. However, neonates are unable to be discharged home on donor milk. Therefore, as a neonate matures, the decision between discharging home on formula or mother's own milk (MOM) occurs. To date, no study has evaluated if there is a detectable threshold for the use of MOM during hospitalization that predicts successful later expressed breast milk (EBM) feeds and absence of formula feeding.
STUDY DESIGN:
This was a prospective cohort study of all neonates and infants with a birth weight of <1,500 grams. Neonates were enrolled within 72 hours of birth. Percentage of MOM compared to overall enteral feeds throughout hospitalization was monitored in addition to growth velocities including weight, length and head circumference gains from birth to discharge. Infant outcomes included known morbidity and mortality measures, and if the neonate was discharged home on exclusive EBM feeds. RESULTS: Among the 117 neonates included in the study, for every 1 percent increase in the percentage of MOM, the odds of being discharged home on a human milk diet increased by 4.4% (OR 1.04, 95% CI: 1.03-1.06, p<0.001). When examining the ability of percent MOM to predict discharge home on EBM, a cutoff of >45.4% MOM feedings accurately predicted discharge on EBM with a sensitivity of 89%, specificity of 79% and a positive predictive value of 88% (Figure 1) . CONCLUSION: These findings indicate that by simply increasing the amount of MOM by 1% a VLBW neonate receives during hospitalization, the odds of being discharged home on EBM feeds increases by 4.4%. Both obstetrical and neonatal care providers can focus on strategies to increase MOM usage during hospitalization such as frequent "pumping", scheduled breast feedings, and ensuring counseling of the importance of breast feeding. These combinatorial efforts can meaningfully improve the likelihood of neonates being discharged home on EBM, and patients can be counseled that if they express milk with MOM at least half of the time during hospitalization, then they are likely to meet the goals of exclusive breastfeeding.
937 Decreased rates of necrotizing enterocolitis associated with exclusive human milk-based diet OBJECTIVE: Necrotizing enterocolitis (NEC) is a multifactorial disease of the intestinal tract associated with significant morbidity and mortality in neonates. The highest risk for developing NEC are neonates <1,000 grams, <28 weeks, or with congenital heart defects. The American Academy of Pediatrics recommends human milk (HM), including donor milk (DM), for preterm infants. As such, exclusive HM diets in extremely low birth weight (ELBW) infants
